VRNA - Total Utang marang Modal Verona Pharma Inc.

Logo perusahaan publik Verona Pharma plc (VRNA)

High barriers to entry in respiratory medicine, driven by costly trials and patents, dictate the dynamics of the debt load for Verona Pharma plc (VRNA). When reviewing the total debt-to-equity ratio on GURU.Markets, it is evident that 0.83 determines the magnitude of the metric. This is based on the commercialization of unique COPD medications and the impeccable condition of the company's production capacities.

VRNA: Total Utang marang Modal Verona Pharma 04.07.2022 - 18.10.2025

Rincian analitis perusahaan Verona Pharma plc

- rega lan prakiraan konsensus rega:
Bagan rega Verona Pharma|VRNA - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Verona Pharma|VRNA - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Verona Pharma|VRNA - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku veronapharma.com|VRNA - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Verona Pharma plc|VRNA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Verona Pharma plc|VRNA - Gunggung utang perusahaan|Utang marang nilai buku Verona Pharma|VRNA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Verona Pharma|Indikator likuiditas cepet veronapharma.com
- informasi bathi lan kelipatan valuasi:
VRNA - Bathi sawise mbayar pajeg
Analisis dhasar perusahaan:Verona Pharma
Barang utama Verona Pharma Inc.

Verona Pharma plc (VRNA) is moving toward the commercialization of Ohtuvayre following FDA approval. The debt-to-equity ratio trend reflects the balance between borrowed funds and net assets. This metric measures the degree of financial leverage by comparing total liabilities to shareholders' equity. An increase in this ratio that outpaces revenue growth signals liquidity risks. The stability of this proportion confirms the company's resilience during its sales expansion period.

Analisis pesaing Verona Pharma plc

Utang marang Ekuitas Haleon|Kenvue Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal MENS|LGND (Ligand Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal AMRX (Amneal Pharmaceuticals)|Total Utang marang Modal perrigo.com PRGO|ALVO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Total Utang marang Modal|Total Utang marang Modal amphastar.com|Rasio Total Utang marang Ekuitas PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Theravance TBPH|Aquestive Corp (AQST) - Utang marang Modal|SCPH: Rasio Total Utang marang Ekuitas|Tectonic Therapeutic, Inc. - Utang Agregat marang Modal|TNXP: Total Utang marang Modal|China SXT Pharmaceuticals, Inc. - Rasio Kabeh Utang marang Dana Pribadi|EPRX (Eupraxia Pharmaceuticals, Inc.) - Total Utang marang Modal|Utang marang Modal BioHarvest Sciences Inc BHST|Utang marang Ekuitas eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Rasio Kabeh Utang marang Dana Pribadi|Entera Bio - Rasio Total Utang marang Ekuitas|MindWalk Holdings, Inc. - Utang marang Ekuitas|ABVC BioPharma Inc - Total Utang marang Modal|Utang marang Modal Cumberland Corp|Quantum BioPharma Ltd (QNTM) - Utang marang Ekuitas|fibrogen.com - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Telomir Pharmaceuticals, Inc.|Utang marang Modal Rani Therapeutics Inc RANI|Utang marang Ekuitas Synergy CHC Corp (SNYR)|rallybio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|Total Utang marang Modal pulmatrix.com PULM|PTHL: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi APM (Aptorum Group Limited)|Lyra Therapeutics, Inc (LYRA) - Utang marang Ekuitas|Utang Agregat marang Ekuitas IBO (Impact BioMedical, Inc.)|TNFA (TNF Pharmaceuticals Inc.) - Total Utang marang Modal|YCBD: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PRFX|Total Utang marang Modal altamiratherapeutics.com (CYTO)|Utang marang Ekuitas Lipella LIPO|Rasio Kabeh Utang marang Dana Pribadi OPTN|PIRS - Utang marang Ekuitas|procapsgroup.com (PROC) - Rasio Total Utang marang Ekuitas|PTPI: Total Utang marang Modal|Qilian International Holding Group (QLI) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas SLRN|TFFP: Rasio Kabeh Utang marang Dana Pribadi